Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
暂无分享,去创建一个
W. Kim | Adrian M Di Bisceglie | A. D. Di Bisceglie | Steven L Flamm | H. Bodenheimer | W Ray Kim | S. Flamm | Henry C Bodenheimer
[1] G. Bray,et al. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome , 2006, Endocrine.
[2] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[3] D. Mozaffarian,et al. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States , 2006, Hepatology.
[4] S. Haffner,et al. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. , 2005, Diabetes.
[5] M. Yuen,et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications , 2005, Gut.
[6] T. Nakajima,et al. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase. , 2005, Journal of hepatology.
[7] A. Lazenby,et al. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women , 2005, Hepatology.
[8] T. Therneau,et al. Mortality and hospital utilization for hepatocellular carcinoma in the United States. , 2005, Gastroenterology.
[9] W. Markiewicz,et al. Association Between Elevated Liver Enzymes and C-Reactive Protein: Possible Hepatic Contribution to Systemic Inflammation in the Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[10] L. Kundrotas,et al. Serum alanine aminotransferase (ALT) elevation in asymptomatic US air force basic trainee blood donors , 1993, Digestive Diseases and Sciences.
[11] M. Camilo,et al. Nonalcoholic steatohepatitis , 2005, Digestive Diseases and Sciences.
[12] K. Flegal,et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.
[13] I. Suh,et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study , 2004, BMJ : British Medical Journal.
[14] Brian P. Mulhall,et al. Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.
[15] K. McGlynn,et al. The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update , 2003, Annals of Internal Medicine.
[16] B. Portmann,et al. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT , 2003, American Journal of Gastroenterology.
[17] M. Yuen,et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy , 2003, Gut.
[18] J. Everhart,et al. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.
[19] R. Green,et al. AGA technical review on the evaluation of liver chemistry tests. , 2002, Gastroenterology.
[20] A. Zanella,et al. Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.
[21] W. Kim,et al. Burden of liver disease in the United States: Summary of a workshop , 2002, Hepatology.
[22] Jacques Ferlay,et al. Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.
[23] H. Kumada,et al. [Chronic hepatitis B]. , 2001, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.
[24] W. Kim,et al. Outcome of hospital care of liver disease associated with hepatitis C in the United States , 2001, Hepatology.
[25] J. Raufman,et al. Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels. , 2000, The American journal of medicine.
[26] E L Murphy,et al. Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.
[27] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[28] G. Gerken,et al. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals , 1999, Hepatology.
[29] A. Frydén,et al. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. , 1999, Scandinavian journal of gastroenterology.
[30] K. Lindor,et al. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease , 1999, American Journal of Gastroenterology.
[31] H. El‐Serag,et al. Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.
[32] M. Bardella,et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease , 1999, Hepatology.
[33] D. Vlahov,et al. A prospective, community‐based evaluation of liver enzymes in individuals with hepatitis C after drug use , 1999, Hepatology.
[34] A. Blei,et al. Diurnal variation of serum alanine transaminase activity in chronic liver disease , 1998, Hepatology.
[35] J. M. Calvo Romero,et al. Gastric adenocarcinoma and kidney transplantation , 1998 .
[36] J. Delattre,et al. Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C , 1998, Hepatology.
[37] F. Gordon,et al. AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus Infection , 1998, American Journal of Gastroenterology.
[38] J. Emparanza,et al. [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.
[39] G. Tytgat,et al. Primary Sclerosing Cholangitis: A Clinical Review , 1998, American Journal of Gastroenterology.
[40] A. Magrini,et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels , 1997, Hepatology.
[41] P. Bedossa,et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.
[42] G. Weinstock,et al. Human glutamate pyruvate transaminase (GPT): localization to 8q24.3, cDNA and genomic sequences, and polymorphic sites. , 1997, Genomics.
[43] J W Shih,et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. , 1996, The New England journal of medicine.
[44] Ruth E. Brown,et al. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. , 1995, JAMA.
[45] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: an expanded clinical entity. , 1994, Gastroenterology.
[46] C G Fraser,et al. Biological variation in clinical chemistry. An update: collated data, 1988-1991. , 1992, Archives of pathology & laboratory medicine.
[47] K. Titani,et al. Complete amino acid sequence of human liver cytosolic alanine aminotransferase (GPT) determined by a combination of conventional and mass spectral methods. , 1991, Biochemistry.
[48] A. Salvaggio,et al. Body mass index and liver enzyme activity in serum. , 1991, Clinical chemistry.
[49] P. Adams,et al. Clinical presentation of hemochromatosis: a changing scene. , 1991, The American journal of medicine.
[50] K. Summers,et al. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index , 1990, Hepatology.
[51] R. Crystal,et al. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. , 1990, The Journal of clinical investigation.
[52] J. Hoofnagle,et al. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. , 1988, Gastroenterology.
[53] B. Portmann,et al. RISK FACTORS IN DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CIRRHOSIS: PROSPECTIVE STUDY OF 613 PATIENTS , 1985, The Lancet.
[54] J. Ewing,et al. Detecting alcoholism. The CAGE questionnaire. , 1984, JAMA.
[55] J. Boitnott,et al. Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. , 1984, Gastroenterology.
[56] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.
[57] R. Wright. Liver and biliary disease: Pathophysiology, diagnosis, management , 1979 .
[58] F. Szalay,et al. OSTEOPOROSIS AND ANDROGENS , 1976, The Lancet.
[59] G. Siest,et al. Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. , 1975, Clinical chemistry.
[60] M. Selzer. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. , 1971, The American journal of psychiatry.
[61] Wilson Jm,et al. Principles and practice of mass screening for disease , 1968 .
[62] F. Nuttall,et al. Creatine kinase and glutamic oxalacetic transaminase activity in serum: kinetics of change with exercise and effect of physical conditioning. , 1968, The Journal of laboratory and clinical medicine.
[63] Ja Wilson,et al. Principles and practice of screening for disease , 1968 .